期刊文献+

后程三维适形放射治疗老年局部晚期非小细胞肺癌疗效观察 被引量:1

下载PDF
导出
摘要 目的:分析探讨普通放疗后加后程三维适形放射治疗70岁以上老年局部晚期非小细胞肺癌(NSCLC)的临床疗效。方法:回顾分析普通放疗后后程三维适形放射治疗70岁以上老年局部晚期非小细胞肺癌132例,普通放疗DT30~40Gy,三维适形放射治疗放射剂量DT26~36Gy。结果:中位生存时间为16个月,1,2,5年生存率分别为57.6%,34.8%,8.3%。结论:老年局部晚期NSCLC的治疗尚无统一方案,后程三维适形放射治疗70岁以上老年局部晚期NSCLC不良反应较轻,患者对急性反应可以耐受,能提高局部控制率,提高生存率,是老年局部晚期非小细胞肺癌可选择的无创治疗方法。
机构地区 晋城市人民医院
出处 《临床医药实践》 2012年第10期745-747,共3页 Proceeding of Clinical Medicine
  • 相关文献

参考文献3

二级参考文献21

  • 1杨秋敏.长春瑞滨联合放疗对老年晚期非小细胞肺癌患者生活质量的影响[J].中国临床康复,2004,8(26):5512-5513. 被引量:2
  • 2欧广飞,王绿化,张红星,陈东福,肖泽芬,冯勤付,周宗玫,吕纪马,梁军,汪楣,殷蔚伯.289例局部晚期非小细胞肺癌放疗和放化综合治疗结果[J].中华放射肿瘤学杂志,2007,16(2):86-90. 被引量:30
  • 3[1]Egorin MJ. Cancer pharmacology in the elderly. Semin Oncol,1993,20(1):43-49.
  • 4[2]Vose JM. Cytokine use in the older patient.Semin Oncol,1995,22(1 suppll):6-8.
  • 5[3]Cohen HJ.Geriatric principles of treatment applied to medical oncology .an overview.Semin Oncol,1995,22(1 sup.):1-2.
  • 6[4]Oshita F,Kurata T,KasaiT,et al. Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Jpn.J.Cancer Res,1995,86(12):1198-1202.
  • 7[5]Sweebey CJ, Sabdker AB. Treatment of advanced (stageⅢ andⅣ) non-small cell lung cancer.Curr Probl Cancer,1998,22(2):87-132.
  • 8Reckzeh B, Merte H, Pfluger KH, et al. Severe lymphocgfopenia and intertitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer[J]. J Clin Oneol,1996,14(4):1071-1076.
  • 9Choy H, Yee L, Cole BF, Combined-modality therapy for advanced non-small-cell lung cancer: paclitaxel and theracic irradiation[J].Semin Oncol, 1995,22(15sup):38-44.
  • 10Cohen HJ. Geriatric principles of threatment applied to medical oncology. An overview[J]. Senim Oncol, 1995, 22(lsup):1-2.

共引文献42

同被引文献5

  • 1王洁.重视表皮生长因子受体抑制剂相关皮肤副反应.中国医学论坛报,2008,1101(4):10-10.
  • 2Thatcher N,Chang A,Parikh P,et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer:results from a randomized,placebo controlled,multi- centre study(Iressa Survival Evaluation in Lung Can- cer)[J]. Lancet,2005,366(9 496) ,1 527-1 537.
  • 3Shepherd F A, Pereira J R, Ciuleanu T, et al. Er- lotinib in previously treated non small cell lung can- cer[J]. N Engl J Med, 2005,353(2) : 123-132.
  • 4Thatcher N,Chang A. Gefitinib plus best supportive care in previously treated patients with refyactory advanced non small cell lung cancer : results from a randomized, placebo controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)[J]. Lancet,2005(366):1 527-1 537.
  • 5滕英,赵金奇.24例非小细胞肺癌晚期易瑞沙分子靶向治疗的观察及护理[J].华北煤炭医学院学报,2010,12(2):252-252. 被引量:3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部